Dr. Amy Erica Lin is a cardiologist who cares for patients with cancer by addressing the cardiovascular side effects of cancer treatments. Her special interests include breast cancer survivorship and clonal hematopoiesis of indeterminate potential, or CHIP (mutations in stem cells of the blood).
Lin's research focuses on cardio-oncology (preventing and managing heart problems that can result from cancer therapies), looking particularly at inflammation in cardiovascular disease and how CHIP can increase a patient's risks for heart disease, heart failure and arrhythmias.
Lin earned her medical degree and a doctorate in medical biophysics at the University of Toronto, where she also completed a residency in internal medicine. She completed a fellowship in cardiovascular medicine at Brigham and Women's Hospital, an affiliate of Harvard Medical School, and a postdoctoral fellowship in cardiology and hematology-oncology at Mass General Brigham and the Dana-Farber Cancer Institute.
University of Toronto, MD, 2012
University of Toronto, Internal Medicine, 2016
Brigham and Women's Hospital, Cardiovascular Medicine, 2019
Brigham and Women's Hospital, Hematology and Oncology, 2022
Assistant Professor
